Precision BioLogic will present data at the World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, Scotland, May 20-24. Recognizing the need to improve Factor VIII (FVIII) inhibitor testing for people with hemophilia A, the company studied the agreement between a chromogenic Modified Nijmegen-Bethesda Assay (MNBA) and a qualitative ELISA test in the detection of FVIII inhibitors in plasma samples.
home
News & Events
On The Fritsma Factor
From Ruth Spates: Hi George, our mixing study procedure requires the patient...